BOT 4.76% 33.0¢ botanix pharmaceuticals ltd

Bot Chart, page-1074

  1. 4,736 Posts.
    lightbulb Created with Sketch. 331
    Permetrex licensing deal(s) of some nature are by far the best chance we have of getting early forms of revenue.

    It's already been clinically proven to be safe and effective.

    Could give many other products a competitive advantage, and require less active ingredient for the same results.

    Huge opportunities here.

    Milesy
    Last edited by milesy: 11/07/19
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
(20min delay)
Last
33.0¢
Change
0.015(4.76%)
Mkt cap ! $597.3M
Open High Low Value Volume
32.5¢ 33.5¢ 32.3¢ $1.265M 3.862M

Buyers (Bids)

No. Vol. Price($)
4 129446 32.5¢
 

Sellers (Offers)

Price($) Vol. No.
33.0¢ 131308 2
View Market Depth
Last trade - 16.10pm 09/08/2024 (20 minute delay) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.